Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
This is a 14.3% decrease from the number of companies inspected in the previous quarter, when seven companies received seven inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. The second most common type of company inspected worked in the Biologics sector.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Atlantic Fertility Center Partners, LLC | Biologics | 01/17/2025 | No Action Indicated (NAI) |
| Carolina Conceptions, PA | Biologics | 01/16/2025 | No Action Indicated (NAI) |
| Chapel Hill Toffee | Food and Cosmetics | 03/18/2025 | No Action Indicated (NAI) |
| Horner International, Inc. | Food and Cosmetics | 02/25/2025 | No Action Indicated (NAI) |
| Southern Foods, LLC | Food and Cosmetics | 01/28/2025 | No Action Indicated (NAI) |
| United Therapeutics Corporation | Drugs | 02/28/2025 | Voluntary Action Indicated (VAI) |
Alerts Sign-up